The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...
At Stage 5 of the Global Deterioration Scale, a person can’t safely live without assistance. Unfortunately, the treatments at this stage are of limited benefit.
There remains controversy in the scientific community about the benefit of statins in women, because women have been less studied than men.